JPMorgan Chase & Co’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-44,902
| Closed | -$32.2K | – | 6653 |
|
|
2024
Q1 | $32.2K | Buy |
44,902
+17,048
| +61% | +$12.2K | ﹤0.01% | 5111 |
|
|
2023
Q4 | $23.7K | Buy |
27,854
+229
| +0.8% | +$195 | ﹤0.01% | 5209 |
|
|
2023
Q3 | $37.8K | Sell |
27,625
-6,451
| -19% | -$8.84K | ﹤0.01% | 4984 |
|
|
2023
Q2 | $85.9K | Buy |
34,076
+33,964
| +30,325% | +$85.6K | ﹤0.01% | 4698 |
|
|
2023
Q1 | $0 | Buy |
+112
| New | – | ﹤0.01% | 6206 |
|